Truvia®, the #1 natural zero calorie sweetener, announced the launch of a multimillion dollar integrated marketing campaign, “From Nature. For Sweetness.” The new creative campaign, kicked off on September 24th, will further drive consumer awareness, trial and adoption of Truvia® products in the U.S. Since opening the U.S. market for stevia-based sweeteners in 2008, the Truvia® brand has led the natural sweetener category and now holds a 61 percent market share.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58203-truvia-from-nature-for-sweetness-campaign-spotlights-stevia-sweetener
New research has revealed that the use of Antimicrobial Copper surfaces in hospital rooms can reduce the number of healthcare-acquired infections (HAIs) by 58% as compared to patients treated in Intensive Care Units with non-copper touch surfaces. In the United States, 1 out of every 20 hospital patients develops an HAI, resulting in an estimated 100,000 deaths per year. Although numerous strategies have been developed to decrease these infections, Antimicrobial Copper is the only strategy that works continuously, has been scientifically proven to be effective and doesn’t depend on human behavior, according to a recently published study in the SHEA Journal of Infection Control and Hospital Epidemiology.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61120-antimicrobial-copper-surfaces-reduce-healthcare-acquired-infections
SIRO Clinpharm, a leading full service clinical research organization, unveiled its new brand identity on Friday. The new look affirms the recent transformation in the company’s business strategy.
“With the vast experience garnered over the past 16 years, SIRO was set to take a leap forward. With its customer centric leadership, we have built depth in various areas of competencies, leveraging our 4 pillars – people, processes, technologies and solutions,” said Dr. Gautam Daftary, founder and chairman, SIRO Clinpharm.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58672-SIRO-Clinpharm-unveils-new-brand-identity
Reproductive Medicine Associates of New Jersey (http://www.rmanj.com) today presented interim findings from its BEST (Blastocyst Euploid Selective Transfer) trial, the first well-controlled clinical trial comparing in vitro fertilization (IVF) pregnancy rates in a group of women receiving a single embryo transfer (SET) with comprehensive chromosome screening (CCS) with a group receiving traditional morphology-based double embryo transfer (DET). The findings were presented at the American Society for Reproductive Medicine 68th Annual Meeting in San Diego, October 20-24, 2012.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58883-rmanj-best-trial-results-ivf-pregnancy-rates-women-asrm-annual-meeting
Three and a half years after beginning a clinical trial which demonstrated the first successful and sustained use of genetically engineered T cells to fight leukemia, a research team from the Perelman School of Medicine at the University of Pennsylvania and the Children’s Hospital of Philadelphia will today announce the latest results of studies involving both adults and children with advanced blood cancers that have failed to respond to standard therapies. The findings from the first 59 patients who received this investigational, personalized cellular therapy, known as CTL019, will be presented during the American Society of Hematology’s Annual Meeting and Exposition in New Orleans.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64691-penn-medicine-reports-research-leukemia-patients-cellular-therapy-ctl019
For the millions who suffer from Gastroesophageal Reflux Disease (GERD), a study published today in the New England Journal of Medicine (NEJM) provides clinical evidence of safety and effectiveness for a new, FDA-approved medical device. Torax Medical’s LINX® Reflux Management System was studied in a controlled, prospective, multicenter trial involving 14 U.S. and European medical centers as part of the FDA pre-market approval process. The patients were evaluated before and after treatment to determine the effect of the LINX System on their GERD using pre-defined success criteria, which included reduction of esophageal acid, improvement in quality of life and elimination of reflux medications.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60077-torax-medical-linx-reflux-management-system-clinical-study-published
Turn Your Dull Pictures Taken from Mobile into Vibrant Pics That Speak a Million Words. Learn For Free, Few Chapters Are Being Taught by a 9 year Old 5th Grade Girl, Which Has Become the Talking Point of Media Worldwide. Watch the Preview Promo to know different ways of how you can make your pictures stunning enough to post on the Social Media. A 9 year old 5th grade girl teaches you few amazing tricks that can transform your pictures instantly. Before experimenting any new look at beauty salon, you can first try it on your photograph. Now pimples & acne can't hide the actual beauty of yours, learn how to make your pimples & acne do the vanishing act on your photograph With RK Photo magic trix. Use Trial & Error methods to find out which colors of your Lipstick, Eye Shadow, Tattoo, Blush On, Mehndi, Dress Color & Hairstyle looks best on you, also learn to do extreme make up on your photographs. Listen to the peppy African Theme song recorded in Africa & Sung by an African. A fifth standard girl Arkshya Raj Kalra along with her father is teaching some interesting & simple tricks of Photoshop & in the process the International Media has already started talking & writing about this simplified tutorials aimed at rectifying the problems that everyone faces in their pictures. For more updates and Photo Trix ... like RKPhotoMagicTrix Facebook page --
https://www.facebook.com/rkphotomagictrix
The Studio365 mobile app by Live365 mobile app enables broadcasters to manage their radio stations anywhere they go. With the Studio365 mobile app you can: • Create, preview, and manage your Shout Out Messages • Set and update your pre-rolls and station ID messages • Update your profile including title, image, description, etc. • Check your listener stats in real time • Listen and share your station anywhere New features coming soon To
use the Studio365 app, a Live365 broadcasting account is required. To
learn more about broadcasting with Live365, and to get a free 7 day
personal broadcasting trial using the Live365 platform, visit
http://www.live365.com/dj
The Alfred Mann Foundation (AMF) today announced the first subject, a U.S. Marine, SSgt James Sides, as a recipient of its highly anticipated IMES System (implantable myoelectric sensor) – an experimental system that holds the promise of being the first minimally invasive, intuitive, multi-channel control system for prosthetics intended for long term use. The IMES System is currently being studied under the Investigational Device Exemption (IDE) regulations of the U.S. Food and Drug Administration (FDA). AMF’s ongoing trial with injured veterans at the Walter Reed National Medical Military Center anticipates subjects intuitively operating three different prosthetic movements simultaneously: opening and closing the hand, rotating the wrist, and moving the thumb. Combining these three movements enables several grasps that are invaluable for performing everyday tasks.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65112-alfred-mann-foundation-u-s-marine-subject-fda-study-for-imes-system
http://FreeGames24-7.com Video Games? We Got Games! Free Unlimited PC Play! Start your One Month Free Trial Here. You're gonna love it or cancel with no cost or obligation.
Zensun Sci & Tech, Ltd., a biopharmaceutical company based in Shanghai and San Diego, announced today positive results of four completed Phase 2 clinical trials including three double-blind, placebo-controlled studies conducted in China and Australia and interim results from the United States Phase 2 trial for Zensun’s innovative “first-in-class” anti-heart failure drug, Neucardin™.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61677-zensun-completes-clinical-trials-of-neucardin-treatment-of-heart-failure
The Great Depression was a time of sacrifice, and sixteen-year-old Sooze Williams chooses to sacrifice her heart and her future to help her family and save her brother. A murder, a betrayal, a trial. If you like Steinbeck and Grisham you will want to read Shadow of the Hawk by K.S. Jones. Find out more at http://ksjones.com. #ShadowoftheHawk Thriller/Literary/YA
